Sino Biopharmaceutical Ltd
HKEX:1177
Wall Street
Price Targets
Price Targets Summary
Sino Biopharmaceutical Ltd
According to Wall Street analysts, the average 1-year price target for
Sino Biopharmaceutical Ltd
is 4.81 HKD
with a low forecast of 3.84 HKD and a high forecast of 6.51 HKD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Sino Biopharmaceutical Ltd
For the last 8 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
11%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sino Biopharmaceutical Ltd's stock price target?
Price Target
4.81
HKD
According to Wall Street analysts, the average 1-year price target for
Sino Biopharmaceutical Ltd
is 4.81 HKD
with a low forecast of 3.84 HKD and a high forecast of 6.51 HKD.
What is Sino Biopharmaceutical Ltd's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
11%.
What is Sino Biopharmaceutical Ltd's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
11%.
What is Sino Biopharmaceutical Ltd's Net Income forecast?
Projected CAGR
4%
For the last 8 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's net income is
10%.
The projected
CAGR
for the next 3 years is
4%.
You don't have any saved screeners yet
